86 related articles for article (PubMed ID: 7990127)
1. Isolation of a peptide antagonist to the thrombin receptor using phage display.
Doorbar J; Winter G
J Mol Biol; 1994 Dec; 244(4):361-9. PubMed ID: 7990127
[TBL] [Abstract][Full Text] [Related]
2. Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists.
Seiler SM; Peluso M; Tuttle JG; Pryor K; Klimas C; Matsueda GR; Bernatowicz MS
Mol Pharmacol; 1996 Jan; 49(1):190-7. PubMed ID: 8569706
[TBL] [Abstract][Full Text] [Related]
3. Development of potent thrombin receptor antagonist peptides.
Bernatowicz MS; Klimas CE; Hartl KS; Peluso M; Allegretto NJ; Seiler SM
J Med Chem; 1996 Dec; 39(25):4879-87. PubMed ID: 8960546
[TBL] [Abstract][Full Text] [Related]
4. Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides.
Connolly TM; Condra C; Feng DM; Cook JJ; Stranieri MT; Reilly CF; Nutt RF; Gould RJ
Thromb Haemost; 1994 Oct; 72(4):627-33. PubMed ID: 7878643
[TBL] [Abstract][Full Text] [Related]
5. Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes.
Maryanoff BE; Santulli RJ; McComsey DF; Hoekstra WJ; Hoey K; Smith CE; Addo M; Darrow AL; Andrade-Gordon P
Arch Biochem Biophys; 2001 Feb; 386(2):195-204. PubMed ID: 11368342
[TBL] [Abstract][Full Text] [Related]
6. ADP-dependence of platelet activation induced by a thrombin receptor agonist.
Savi P; Dol F; Herbert JM
Nouv Rev Fr Hematol (1978); 1993 Apr; 35(2):115-9. PubMed ID: 8392699
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of the two forms of GPIb functioning as receptors for alpha-thrombin and von Willebrand factor: Ca2+ responses of protease-treated human platelets activated with alpha-thrombin and the tethered ligand peptide.
Greco NJ; Jones GD; Tandon NN; Kornhauser R; Jackson B; Jamieson GA
Biochemistry; 1996 Jan; 35(3):915-21. PubMed ID: 8547273
[TBL] [Abstract][Full Text] [Related]
8. Thrombin receptor agonist peptide induction of mitogenesis in CCL39 cells.
Reilly CF; Connolly TM; Feng DM; Nutt RF; Mayer EJ
Biochem Biophys Res Commun; 1993 Feb; 190(3):1001-8. PubMed ID: 8382482
[TBL] [Abstract][Full Text] [Related]
9. In vitro effect of a thrombin inhibition peptide selected by phage display technology.
Meiring MS; Litthauer D; Hársfalvi J; van Wyk V; Badenhorst PN; Kotzé HF
Thromb Res; 2002 Sep; 107(6):365-71. PubMed ID: 12565725
[TBL] [Abstract][Full Text] [Related]
10. Issues in the development of thrombin receptor antagonists.
Brass LF
Thromb Haemost; 1995 Jul; 74(1):499-505. PubMed ID: 8578513
[TBL] [Abstract][Full Text] [Related]
11. Determination of the putative binding sites for thrombin receptor activating peptide through a hydropathic complementary approach.
Suttnar J; Dyr JE; Dolecková L
Thromb Haemost; 2000 Jan; 83(1):165-70. PubMed ID: 10669171
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin displayed on filamentous phage as a receptor-specific agonist.
Rousch M; Lutgerink JT; Coote J; de Bruïne A; Arends JW; Hoogenboom HR
Br J Pharmacol; 1998 Sep; 125(1):5-16. PubMed ID: 9776337
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
[TBL] [Abstract][Full Text] [Related]
14. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
[TBL] [Abstract][Full Text] [Related]
15. Release of the thrombin receptor (PAR-1) N-terminus from the surface of human platelets activated by thrombin.
Ramachandran R; Klufas AS; Molino M; Ahuja M; Hoxie JA; Brass LF
Thromb Haemost; 1997 Sep; 78(3):1119-24. PubMed ID: 9308764
[TBL] [Abstract][Full Text] [Related]
16. Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface.
Gerszten RE; Chen J; Ishii M; Ishii K; Wang L; Nanevicz T; Turck CW; Vu TK; Coughlin SR
Nature; 1994 Apr; 368(6472):648-51. PubMed ID: 8145852
[TBL] [Abstract][Full Text] [Related]
17. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.
Kuliopulos A; Covic L; Seeley SK; Sheridan PJ; Helin J; Costello CE
Biochemistry; 1999 Apr; 38(14):4572-85. PubMed ID: 10194379
[TBL] [Abstract][Full Text] [Related]
18. Designing scaffolds of peptides for phage display libraries.
Uchiyama F; Tanaka Y; Minari Y; Tokui N
J Biosci Bioeng; 2005 May; 99(5):448-56. PubMed ID: 16233816
[TBL] [Abstract][Full Text] [Related]
19. Molecular requirements involving the human platelet protease-activated receptor-4 mechanism of activation by peptide analogues of its tethered-ligand.
Moschonas IC; Kellici TF; Mavromoustakos T; Stathopoulos P; Tsikaris V; Magafa V; Tzakos AG; Tselepis AD
Platelets; 2017 Dec; 28(8):812-821. PubMed ID: 28267389
[TBL] [Abstract][Full Text] [Related]
20. Contributions of glycoprotein Ib and the seven transmembrane domain receptor to increases in platelet cytoplasmic [Ca2+] induced by alpha-thrombin.
Greco NJ; Tandon NN; Jones GD; Kornhauser R; Jackson B; Yamamoto N; Tanoue K; Jamieson GA
Biochemistry; 1996 Jan; 35(3):906-14. PubMed ID: 8547272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
